Ginkgo seeds could exert anti-neuroinflammatory effects by acting on receptor proteins such as Akt1 through the lipid and atherosclerosis and PI3K-Akt signaling pathways, reducing the phosphorylation level of Akt1, and thereby delaying the process of central sensitization and alleviating migraine symptoms. This evidence concerns the gene AKT1 and migraine disorder.